Get started
Work

1430 Safety and Efficacy of Boceprevir/peginterferon/ Ribavirin (boc/p/r) Combination Therapy for Chronic Hcv G1 Patients With Compensated Cirrhosis: a Meta-analysis of Five Phase 3 Clinical Trials

Year: 2013
Type: review
DOI: 10.1016/s0168-8278(13)61429-4
Authors: J.M. Vierling, S. Zeuzem, F. Poordad, J.-P. Bronowicki, M.P. Manns, B.R. Bacon, R. Esteban, S.L. Flamm, P.Y. Kwo, L.D. Pedicone, W. Deng, F.J. Dutko, M.J. DiNubile, K.J. Koury, F.A. Helmond, J. Wahl, S. Bruno
Institutions: Baylor College of Medicine, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, University Hospital Frankfurt, Université Pierre-et-Marie-Curie, The University of Texas at San Antonio Health Science Center, Université Paris-Est Créteil, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Texas Liver Institute, Inserm, Medizinische Hochschule Hannover, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université Henri Poincaré, Hôpital Lariboisière, Saint Louis University, Vall d'Hebron Hospital Universitari, Institut Pasteur, Indiana University School of Medicine, Infection et Immunité, Hôpital Necker-Enfants Malades, Human Genetic of Infectious Diseases, Azienda Ospedaliera Fatebenefratelli e Oftalmico
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2330968314
FWCI: 0.466
Cites:
Cited by: 11
Related to: 10